Use of hepatitis C-positive donors in transplantation

Clinics

Volumn 67, Issue 5, 2012, Pages 517-519

  Abdala, Edson ^a   de Azevedo, Luis Sérgio Fonseca ^a   Campos, Silvia Vidal ^a   Caramori, Marlova Luzzi ^a   Costa, Sílvia Figueiredo ^a   Strabelli, Tania Mara Varejão ^a   Pierrotti, Lígia Camera ^a   Varkulja, Glaucia Fernanda ^a   de Almeida, Gisele Madeira Duboc ^a   Shikanai Yasuda, Maria Aparecida ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BLOOD; DONOR; GRAFT SURVIVAL; HEPATITIS C; HUMAN; NOTE; ORGAN TRANSPLANTATION; PATHOLOGY; PRACTICE GUIDELINE; STANDARD; VIROLOGY; VIRUS REPLICATION;

ALGORITHMS; GRAFT SURVIVAL; HEPATITIS C; HUMANS; ORGAN TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; TISSUE DONORS; VIRUS REPLICATION;

EID: 84863961951     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(05)19     Document Type: Note

References (14)

1. Rubin RH, Schaffner A, Speich R. Introduction to the Immunocompromised Host Society Consensus Conference on Epidemiology, Prevention, Diagnosis, and Manegment of Infections in Solid-Organ Transplant Recipients. Clin Infect Dis. 2001;33(Suppl 1):S1-S4, http://dx.doi.org/10.1086/320896.
2. Gross PA, Barrett TL, Dellinger EP, Krause PJ, Martone WJ, McGowan JE Jr, et al. Purpose of quality standards for infectious diseases: Infectious Diseases Society of America. Clin Infect Dis. 1994;18(3):421, http://dx.doi.org/10.1093/clinids/18.3.421.
3. United States Public Health Service/Infectious Diseases Society of America (USPHS/IDSA) Prevention of Opportunistic Infections Working Group. Preface to the USPHS/IDSA guidelines for the prevention of opportunistic infectionsin persons infected with human immunodeficiency virus. Clin Infect Dis. 1997;25(Suppl 3): S299-S311 http://dx.doi.org/10.1086/516251.
4. No authors listed. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant. 2004;4(Suppl 10):10-20, http://dx.doi.org/10.1111/j.1600-6135.2004.00616.x.
5. Saab S, Ghobrial RM, Ibrahim AB, Kunder G, Durazo F, Han S, et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: A matched analysis. Am J Transplant. 2003;3(9):1167-72, http://dx.doi.org/10.1034/j.1600-6143.2003.00189.x.
6. Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, et al. Impact of donor age on survival and fibrosis progressionin patients with hepatitis C undergoing liver transplantation using HCV + allografts. Liver Transpl. 2006;12(10):1496-503, http://dx.doi.org/10.1002/lt.20849.
7. Ballarin R, Cucchetti A, Spaggiari M, Montalti R, Di Benedetto F, Nadalin S, et al. Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: A European multicentric casecontrol study. Transplantation. 2011;91(11):1265-72, http://dx.doi.org/10.1097/TP.0b013e318219eb8f.
8. Burr AT, Li YF, Tseng JF, Saidi RF, Bozorgzadeh A, Shah SA. Survival after liver transplantation using hepatitis C virus-positive donor allografts: Case-controlled analysis of the UNOS database. World J Surg. 2011;35:1590-5, http://dx.doi.org/10.1007/s00268-011-1019-5.
9. Morales JM, Domingo MJ, Fuertes A. Hepatitis C virus in renal transplant patients. Am J Kidney Dis. 1995;26(4):693, http://dx.doi. org/10.1016/0272-6386(95)90612-6.
10. Ali MK, Light JA, Barhyte DY, Sasaki TM, Currier CB Jr, Grandas O, et al. Donor hepatitis C virus does not adversely affect short-term outcomes in HCV + recipients in renal transplantation. Transplantation. 1998;66(12): 1694-7, http://dx.doi.org/10.1097/00007890-199812270-00021.
11. Widell A, Mansson S, Persson NH, Thysell H, Hemodsson S, Blohme I. Hepatitis C superinfection in hepatitis c virus (HCV)-infected patients transplanted with an HCV-infectedkidney. Transplantation. 1995;60(4):642-7, http://dx.doi.org/10.1097/00007890-199510150-00004.
12. Gasink LB, Blumberg EA, Localio AR, Desai SS, Israni AK, Lautenbach E. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients. JAMA. 2006;296:1843-50, http://dx.doi.org/10.1001/jama.296.15.1843.
13. Cotler SJ, Jensen DM, Kesten S. Hepatitis C virus infection and lung transplantation: A survey of practices. J Heart Lung Transplant. 1999;18(5):456-9, http://dx.doi.org/10.1016/S1053-2498(98)00053-9.
14. El-Sayed MH, El-Haddad A, Fahmy AO, Salama II, Mahmud HK. Liver Disease is a major cause of mortality following allogeneic bone-marrow transplantation. Eur J Gastroenterol Hepatol. 2004;16(12):1347-4, http://dx.doi.org/10.1097/00042737-200412000-00019.